LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00021667
47.93 27.76 4417 4421 0.9990 0.9997
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
47.93 27.76 684 4421 0.1547 0.5497
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
47.93 27.76 5945 4421 1.3446 1.0826
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
47.93 27.76 5342 4421 1.2082 1.0524
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
47.93 27.76 5494 4421 1.2426 1.0603
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
47.93 27.76 300 4421 0.0679 0.3846
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
47.93 27.76 5120 4421 1.1580 1.0405
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
49.63 27.76 511 4818 0.1061 0.4793
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
49.63 27.76 4760 4818 0.9880 0.9967
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
49.63 27.76 693 4818 0.1438 0.5411
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
49.63 27.76 6295 4818 1.3065 1.0732
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
49.63 27.76 5717 4818 1.1866 1.0465
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
49.63 27.76 5848 4818 1.2138 1.0528
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
49.63 27.76 288 4818 0.0598 0.3695
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
49.63 27.76 5498 4818 1.1411 1.0358
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
51.33 27.76 482 5117 0.0942 0.4612
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
51.33 27.76 5016 5117 0.9803 0.9947
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
51.33 27.76 786 5117 0.1536 0.5593
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
51.33 27.76 6692 5117 1.3078 1.0726
MN20160318_Q01
J19
MCF 10A-H2B-mCherry Trametinib
0.00021667
51.33 27.76 6043 5117 1.1809 1.0447
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
51.33 27.76 6167 5117 1.2052 1.0502
MN20160318_Q01
N10
MCF 10A-H2B-mCherry Trametinib
0.00021667
51.33 27.76 334 5117 0.0653 0.3917
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
51.33 27.76 5791 5117 1.1317 1.0331
MN20160318_Q01
N21
MCF 10A-H2B-mCherry Trametinib
0.00021667
53.04 27.76 479 5365 0.0893 0.4550
MN20160318_Q01
G22
MCF 10A-H2B-mCherry Trametinib
0.00021667
53.04 27.76 5316 5365 0.9907 0.9976
MN20160318_Q01
G22